SciSparc Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPRC research report →
Companyscisparc.com
SciSparc Ltd. , a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy.
- CEO
- Oz Adler
- IPO
- 2021
- Employees
- 2
- HQ
- Tel Aviv, IL
Price Chart
Valuation
- Market Cap
- $237.14K
- P/E
- -0.01
- P/S
- 0.28
- P/B
- 0.04
- EV/EBITDA
- 0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 73.71%
- Op Margin
- -1022.08%
- Net Margin
- -1422.78%
- ROE
- -704.60%
- ROIC
- -152.55%
Growth & Income
- Revenue
- $856.00K · -34.46%
- Net Income
- $-12,179,000 · -93.81%
- EPS
- $-882.64 · -8980.66%
- Op Income
- $-8,749,000
- FCF YoY
- 18.95%
Performance & Tape
- 52W High
- $80.10
- 52W Low
- $2.98
- 50D MA
- $5.03
- 200D MA
- $18.40
- Beta
- 1.33
- Avg Volume
- 419.56K
Get TickerSpark's AI analysis on SPRC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | DAYAN ALON | other | 0 |
| Mar 18, 26 | Shrem Itschak | other | 0 |
| Mar 1, 22 | Shrem Itschak | other | 6 |
| Mar 18, 26 | Shay Amnon Ben | other | 0 |
| Mar 1, 22 | Shay Amnon Ben | other | 1 |
| Mar 18, 26 | Revach Moshe | other | 0 |
| Mar 1, 22 | Revach Moshe | other | 1 |
| Mar 18, 26 | Adler Oz | other | 0 |
| Mar 1, 22 | Adler Oz | other | 6 |
| Mar 18, 26 | Weiss Amitay | other | 0 |
Our SPRC Coverage
We haven't published any research on SPRC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SPRC Report →